Skip to Content

The originating document has been archived. We cannot confirm the completeness, accuracy and currency of the content.

Re-Covr Injection

This page contains information on Re-Covr Injection for veterinary use.
The information provided typically includes the following:
  • Re-Covr Injection Indications
  • Warnings and cautions for Re-Covr Injection
  • Direction and dosage information for Re-Covr Injection

Re-Covr Injection

This treatment applies to the following species:
Manufacturer: Zoetis


20 mg/mL

ANADA 200-162, Approved by FDA

Re-Covr Injection Caution:

Federal law restricts this drug to use by or on the order of a licensed veterinarian.


Tripelennamine hydrochloride is a white, crystalline material which is stable, nonhygroscopic and readily soluble in water. It is supplied in multiple dose vials containing 20 mg of Tripelennamine Hydrochloride USP per mL.


Tripelennamine hydrochloride is characterized by its capacity to antagonize many of the pharmacologic effects of histamine.

Re-Covr Injection Indications

For use in cattle and horses in conditions in which antihistaminic therapy may be expected to lead to alleviation of some signs of disease.


Do not use in horses intended for food purposes.

Milk that has been taken during treatment and for 24 hours (two milkings) after the last treatment must not be used for food.

Treated cattle must not be slaughtered for food during treatment and for four days following the last treatment.

WARNING: A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to be processed for veal.

Re-Covr Injection Caution

Central nervous system stimulation in the form of hyperexcitability, nervousness and muscle tremors lasting up to 20 minutes have been noted in horses, particularly following intravenous administration; therefore, only the intramuscular route of administration should be used in horses.

Overdosage of tripelennamine hydrochloride may give rise to excitement, ataxia and convulsions.

Depression of the central nervous system and incoordination may occur when the drug is used at therapeutic dose levels.

Disturbances in gastrointestinal function may occur in some instances.

While poisonous snake bites have been treated with antihistaminic drugs, other conjunctive therapy is required because of toxic reactions associated with the protein complex of venom.

Re-Covr Injection Dosage And Administration

Warm the solution to near body temperature. Using aseptic precautions, administer intravenously or intramuscularly as specified below. Intramuscular injections should be made into the heavy musculature of the hind leg or cervical area.

The doses specified below may be repeated in 6 to 12 hours if necessary.

Cattle - Administer intravenously or intramuscularly at a dose of 0.5 mg per lb of body weight (2.5 mL for each 100 lbs of body weight). For a more rapid onset of action, the intravenous route of administration is recommended.

Horses - Administer intramuscularly only at a dose of 0.5 mg per lb of body weight (2.5 mL for each 100 lbs of body weight).

How Supplied

Re-Covr Injection (Tripelennamine Hydrochloride Injection) is supplied in 250 mL and 500 mL multiple dose vials containing 20 mg Tripelennamine Hydrochloride USP per mL.


Protect from light. Store between 15°C and 30°C (59°F-86°F). Avoid excessive heat (104°F).

© 2007 Fort Dodge Animal Health. All Rights Reserved.

Manufactured for

Fort Dodge Animal Health, Fort Dodge, Iowa 50501 USA



Rev. 0307


NAC No.: 10031827

Telephone:   269-833-4000
Customer Service:   800-733-5500 and 800-793-0596
Veterinary Medical Investigations & Product Support:   800-366-5288
Technical Services (USA):   800-366-5288
Every effort has been made to ensure the accuracy of the Re-Covr Injection information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2018 North American Compendiums. Updated: 2018-02-26